Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges
Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.
Latest News from Moneycontrol.com
How Animated Explainer Videos Communicate Ideas Visually
Lightning Safety Planning for Homeowners and Families











